In-perspective: the ARAMIS double-blind randomized placebo-controlled trial of anakinra for the treatment of acute myocarditis

Eur Heart J Acute Cardiovasc Care. 2023 Sep 25;12(9):627-628. doi: 10.1093/ehjacc/zuad102.

Authors

David A Morrow¹, Frederik H Verbrugge²

Affiliations

¹ Cardiovascular Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.
² Department of Cardiology, University Hospital Brussels, Brussels, Belgium.

PMID: 37648656
DOI: 10.1093/ehjacc/zuad102

No abstract available

Publication types

Randomized Controlled Trial

MeSH terms

Antirheumatic Agents*
Double-Blind Method
Humans
Interleukin 1 Receptor Antagonist Protein / therapeutic use
Myocarditis* / drug therapy
Treatment Outcome

Substances

Interleukin 1 Receptor Antagonist Protein
Antirheumatic Agents